Genprex Revenue and Competitors
Estimated Revenue & Valuation
- Genprex's estimated annual revenue is currently $5.4M per year.
- Genprex's estimated revenue per employee is $155,000
Employee Data
- Genprex has 35 Employees.
- Genprex grew their employee count by 13% last year.
Genprex's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chairman the Board, President, CEO | Reveal Email/Phone |
2 | SVP, Regulatory Affairs | Reveal Email/Phone |
3 | EVP and COO | Reveal Email/Phone |
4 | SVP Human Resources | Reveal Email/Phone |
5 | VP Manufacturing | Reveal Email/Phone |
6 | SVP | Reveal Email/Phone |
7 | Head Pharmaceutical Development | Reveal Email/Phone |
8 | EVP, General Counsel and Chief Strategy Office | Reveal Email/Phone |
9 | SVP, Regulatory Affairs | Reveal Email/Phone |
10 | SVP Human Resources | Reveal Email/Phone |
Genprex Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Genprex?
Genprex (Nasdaq: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches for patients with cancer and other serious diseases.
keywords:N/A
N/A
Total Funding
35
Number of Employees
$5.4M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Genprex News
Genprex's oncology program utilizes its unique, proprietary, non-viral ONCOPREX® Nanoparticle Delivery System, which the Company believes is the...
Genprex has begun testing a drug candidate based on its systemic gene therapy delivery platform in combination with Merck's Keytruda.
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.
Other Companies in Austin
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.1M | 35 | 30% | N/A |
#2 | $9.2M | 35 | -15% | N/A |
#3 | $3.9M | 35 | N/A | N/A |
#4 | $4.1M | 35 | N/A | N/A |
#5 | $4.1M | 35 | N/A | N/A |